NEW YORK (GenomeWeb) – UK health policy think tank PHG Foundation has released a report detailing recommendations on developing effective testing services for circulating tumor DNA in lung cancer patients.

The report was informed by a workshop the foundation held in March 2017 — which included input from clinicians, UK National Health Service clinical scientists, and representatives from the life science and biotech industry — to identify and focus on the most pressing issues affecting the implementation of effective and equitable ctDNA testing.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.